Stock ACARIX ACARIX AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Acarix AB

Equities

ACARIX

SE0009268717

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:39 2024-05-02 am EDT 		5-day change 1st Jan Change
0.2625 SEK +4.58% Intraday chart for Acarix AB +8.02% +38.30%
Apr. 11 Acarix AB Announces Initiation of the First Us-Based Clinical Workflow Evaluation Study CI
Apr. 08 Acarix Announces the Results from 2024 American College of Cardiology Poster Presentation to Assess the Cost-Utility of the Cadscor System CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 65.91 167.1 219.7 71.81 139.9 207.9 - -
Enterprise Value (EV) 1 12.16 167.1 203.9 60.65 139.9 203.9 207.9 207.9
P/E ratio -0.7 x -2.32 x -2.36 x - -1.19 x - 2.63 x -
Yield - - - - - - - -
Capitalization / Revenue 35.5 x - 58.4 x 12.3 x 22.4 x 2.39 x 1.09 x 0.75 x
EV / Revenue 6.55 x - 54.2 x 10.4 x 22.4 x 2.35 x 1.09 x 0.75 x
EV / EBITDA -0.29 x - -4.22 x -0.83 x -1.88 x -10.4 x 3.12 x 1.91 x
EV / FCF -0.27 x - -4.24 x -0.81 x -1.72 x -6.58 x 9.45 x -
FCF Yield -366% - -23.6% -124% -58.2% -15.2% 10.6% -
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 51,694 141,045 251,972 251,972 737,189 792,165 - -
Reference price 2 1.275 1.185 0.8720 0.2850 0.1898 0.2625 0.2625 0.2625
Announcement Date 2/20/20 4/20/21 2/17/22 2/16/23 2/15/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1.857 - 3.76 5.822 6.241 86.9 191.3 277.3
EBITDA 1 -42.33 - -48.32 -73.44 -74.46 -19.7 66.6 108.7
EBIT 1 -46.44 - -51.7 -76.48 -77.55 -24.2 57.6 94.9
Operating Margin -2,501.02% - -1,374.89% -1,313.55% -1,242.64% -27.85% 30.11% 34.22%
Earnings before Tax (EBT) 1 -46.43 - -51.73 -76.98 -77.84 -24 58 -
Net income 1 -46.46 -41.5 -51.73 -76.98 -77.84 -24 58 -
Net margin -2,501.83% - -1,375.82% -1,322.31% -1,247.22% -27.62% 30.32% -
EPS 2 -1.830 -0.5100 -0.3700 - -0.1600 - 0.1000 -
Free Cash Flow 1 -44.53 - -48.05 -75.02 -81.37 -31 22 -
FCF margin -2,398.12% - -1,277.93% -1,288.56% -1,303.73% -35.67% 11.5% -
FCF Conversion (EBITDA) - - - - - - 33.03% -
FCF Conversion (Net income) - - - - - - 37.93% -
Dividend per Share - - - - - - - -
Announcement Date 2/20/20 4/20/21 2/17/22 2/16/23 2/15/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q3 2022 Q4 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - 1.653 1.54 1.573 1.174 2.6 10.4 30.4 -
EBITDA 1 - - - -16.43 -21.28 -18.7 -14.5 0.8 12.7
EBIT 1 - -22.61 - -17.23 -22 -19.9 -15.7 -0.3 11.6
Operating Margin - -1,368% - -1,095.1% -1,873.76% -765.38% -150.96% -0.99% -
Earnings before Tax (EBT) - - - - - - - - -
Net income -21.11 - -22 - - - - - -
Net margin - - -1,428.83% - - - - - -
EPS -0.0800 - -0.0500 -0.0400 -0.0300 - - - -
Dividend per Share - - - - - - - - -
Announcement Date 11/16/22 2/16/23 8/31/23 11/9/23 2/15/24 - - - -
1SEK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 53.7 - 15.9 11.2 - 4 - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 -44.5 - -48.1 -75 -81.4 -31 22 -
ROE (net income / shareholders' equity) -56.5% - -56.6% - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 - - - - - 1 5 -
Capex / Sales - - - - - 1.15% 2.61% -
Announcement Date 2/20/20 4/20/21 2/17/22 2/16/23 2/15/24 - - -
1SEK in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Acarix AB

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

1st Jan change Capi.
ACARIX AB Stock Acarix AB
+38.30% 18.12M
SARTORIUS AG Stock Sartorius AG
-15.52% 18.54B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD. Stock Inner Mongolia Furui Medical Science Co., Ltd.
+17.00% 1.85B
SHANGHAI MICROPORT EP MEDTECH CO., LTD. Stock Shanghai MicroPort EP MedTech Co., Ltd.
-0.51% 1.66B
BIOTAGE AB Stock Biotage AB
+25.21% 1.23B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD. Stock Shanghai AoHua Photoelectricity Endoscope Co., Ltd.
-13.90% 989M
CONTEC MEDICAL SYSTEMS CO.,LTD Stock Contec Medical Systems Co.,Ltd
-21.76% 896M
REVENIO GROUP OYJ Stock Revenio Group Oyj
-5.01% 744M
VAREX IMAGING CORPORATION Stock Varex Imaging Corporation
-19.85% 673M
CELLAVISION AB Stock CellaVision AB
+7.31% 490M
Medical Diagnostic & Testing Equipment
  1. Stock Market
  2. Equities
  3. ACARIX Stock
  4. Financials Acarix AB